#USA #Medical Devices #Woburn #Micro Medical #CLI Treatment

Micro Medical Solutions Welcomes New Board Members

Micro Medical Solutions (MMS) has made a significant step forward in its mission to transform healthcare with the recent appointment of a prestigious Board of Directors. This innovative medical device startup is dedicated to addressing Critical Limb Ischemia (CLI) through cutting-edge technologies. The newly formed leadership team includes distinguished professionals from various sectors of the healthcare industry, ensuring that MMS is strategically positioned for rapid growth and impact.

Leadership and Vision

At the helm is Greg Sullivan, the CEO and Chairman of the Board, who highlights the breadth of experience that the new appointees bring. Among them is John Fletcher, Managing Partner Emeritus at Fletcher Spaght, Inc. Known for his leadership roles, including Chairman positions at companies like ClearPoint Neuro and Koru Medical, Fletcher's impressive track record in corporate governance will undoubtedly assist MMS in navigating complex regulatory landscapes.

Equally notable is George Quinoy, a veteran C-suite executive recognized for his success in scaling enterprises within the vascular medical space. Quinoy's extensive background includes successful strategies that led to acquisitions by industry giants. His expertise will be critical as MMS develops its flagship product, the MicroStent™, poised to address significant market needs in vascular treatments.

Also joining the Board is Dr. Joseph Ruggio, a highly respected cardiologist. As the founder and president of Pacific Cardiovascular Associates Medical Group, his clinical insights will guide MMS in aligning product development with patient care needs. Dr. Ruggio's dual role as President and Chief Medical Officer of Via Vitae MSO reflects his commitment to both innovation and the higher standard of care in cardiology.

Completing the Board is Dr. Ronald Solar, a seasoned innovator with a Ph.D. in Biomaterials and Materials Science. With over 45 years of experience in designing medical devices, Dr. Solar's history of founding successful medical device firms positions him as a vital contributor to MMS as it seeks to push the boundaries of medical technology.

A Strategic Move Towards Innovation

The Board's expertise is a testament to MMS's dedication to advancing healthcare technology. With a focus on reducing the impact of CLI, the strategic guidance provided by these leaders is designed to bolster MMS's efforts in bringing transformative solutions to market. As they work on enhancing the MicroStent™, they plan to tackle the challenges faced by interventionalists and improve outcomes for patients suffering from vascular diseases.

Expressing enthusiasm, Sullivan stated, "We are honored to welcome such an eminent group of experts to our Board. Their collective experience in medical device innovation, regulatory strategy, and market expansion will be instrumental as we scale our transformative solutions." This robust leadership is expected to streamline the process of securing necessary approvals and ensuring that MMS meets the evolving needs of the healthcare ecosystem.

Looking Ahead

MMS is poised for a promising future. With a committed Board at its side, the startup is stronger than ever as it strives to evolve the medical landscape. The combination of clinical, academic, and corporate experience within the Board is set to influence significant changes in how CLI and other vascular diseases are treated. As they aim not only to innovate but to ensure patient safety and satisfaction, the leadership at MMS reflects a dedicated commitment to excellence in healthcare.

For more details about Micro Medical Solutions and their innovative approaches to healthcare, visit www.micromedicalsolutions.net.